Pulmonary arterial hypertension target mining verification simulation system integrating multiple omics data
By integrating multi-omics data into a pulmonary hypertension target mining and validation simulation system, the batch effect and single-algorithm overfitting problems in high-dimensional biomedical data processing have been solved, achieving highly specific identification and cross-scale analysis of pulmonary hypertension targets, and supporting the development of targeted drugs.
Patent Information
- Application Number
- CN202610568102.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-27
- Publication Date
- 2026-07-24
AI Technical Summary
Existing technologies suffer from batch effect interference and overfitting of single algorithms when processing high-dimensional biomedical data, resulting in low specificity for pulmonary hypertension target identification and a lack of cross-scale system analysis.
A simulation system for target discovery and validation in pulmonary hypertension using multi-omics data integration includes a data input layer, a differential analysis module, a weighted gene co-expression network analysis module, a protein interaction network analysis module, and a multi-machine learning ensemble screening module. It uses an empirical Bayesian framework to handle batch effects and combines multiple machine learning models for target feature screening and validation.
It improves the specificity and accuracy of pulmonary hypertension target identification, can accurately identify core functional modules, and constructs cross-scale biological analysis models to achieve targeted relocation of small molecule compounds.
